STOCK TITAN

[144] ACM Research, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

ACM Research (ACMR) Form 144 notice reports a proposed sale of 60,000 common shares through Morgan Stanley Smith Barney on 09/04/2025 with an aggregate market value of $1,586,508.00. The shares were acquired and to be sold following a stock option exercise on 09/04/2025 and payment was made in cash. The filing notes 64,180,965 shares outstanding. It also discloses a recent sale by Hui Wang of 70,000 shares on 09/03/2025 for $1,873,711.00. The filer certifies they are not aware of any undisclosed material adverse information.

ACM Research (ACMR) - Avviso Form 144 relativo a una proposta di vendita di 60.000 azioni ordinarie tramite Morgan Stanley Smith Barney in data 09/04/2025, per un valore complessivo di mercato di $1.586.508,00. Le azioni sono state acquisite e saranno vendute a seguito di un esercizio di opzioni su azioni il 09/04/2025, con pagamento effettuato in contanti. Il deposito indica un flottante di 64.180.965 azioni in circolazione. Viene inoltre riportata una vendita recente da parte di Hui Wang di 70.000 azioni il 09/03/2025 per $1.873.711,00. Il dichiarante attesta di non essere a conoscenza di informazioni materiali avverse non divulgate.

ACM Research (ACMR) - Aviso Form 144 que informa sobre una propuesta de venta de 60.000 acciones ordinarias a través de Morgan Stanley Smith Barney el 09/04/2025, por un valor de mercado agregado de $1,586,508.00. Las acciones se adquirieron y se venderán tras un ejercicio de opciones sobre acciones el 09/04/2025, con pago en efectivo. La presentación señala que hay 64,180,965 acciones en circulación. También revela una venta reciente de Hui Wang de 70,000 acciones el 09/03/2025 por $1,873,711.00. El declarante certifica que no tiene conocimiento de información adversa material no divulgada.

ACM Research (ACMR) - Form 144 공고에 따르면 Morgan Stanley Smith Barney를 통해 2025-09-0460,000 보통주를 매도할 예정이며 총 시가 가치는 $1,586,508.00입니다. 해당 주식은 2025-09-04주식옵션 행사로 취득되어 현금으로 결제된 후 매도될 예정입니다. 제출서류에는 총 발행주식수가 64,180,965주로 기재되어 있습니다. 또한 Hui Wang이 2025-09-0370,000주를 $1,873,711.00에 매각한 최근 거래도 공개되어 있습니다. 제출인은 공개되지 않은 중대한 불리한 정보가 없음을 확인합니다.

ACM Research (ACMR) - L'avis Form 144 rapporte une proposition de vente de 60 000 actions ordinaires via Morgan Stanley Smith Barney le 09/04/2025, pour une valeur de marché agrégée de $1,586,508.00. Les actions ont été acquises et seront vendues à la suite d'un exercice d'options sur actions le 09/04/2025, le paiement ayant été effectué en espèces. Le dépôt indique 64,180,965 actions en circulation. Il révèle également une vente récente par Hui Wang de 70,000 actions le 09/03/2025 pour $1,873,711.00. Le déclarant certifie qu'il n'a connaissance d'aucune information défavorable matérielle non divulguée.

ACM Research (ACMR) - Form 144-Meldung berichtet über einen geplanten Verkauf von 60.000 Stammaktien über Morgan Stanley Smith Barney am 09/04/2025 mit einem Gesamtmarktwert von $1.586.508,00. Die Aktien wurden im Zuge der Ausübung einer Aktienoption am 09/04/2025 erworben und werden nach Barausgleich verkauft. Die Einreichung gibt 64.180.965 ausstehende Aktien an. Zudem wird ein kürzlicher Verkauf durch Hui Wang von 70.000 Aktien am 09/03/2025 für $1.873.711,00 offengelegt. Der Einreicher bestätigt, dass ihm keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind.

Positive
  • Disclosure includes acquisition details: the filing specifies the shares were acquired via a stock option exercise on 09/04/2025 and paid in cash.
  • Brokered transaction: the proposed sale is routed through Morgan Stanley Smith Barney, providing a clear execution venue.
Negative
  • Insider selling shares: the filing shows a proposed sale of 60,000 common shares, which is a notable insider disposition.
  • Recent sizable prior sale: the filer disclosed a 70,000-share sale on 09/03/2025 for $1,873,711.00, indicating recent insider selling activity.

Insights

TL;DR: Routine insider sale following option exercise; amount disclosed but no operational or financial details changed.

The filing documents a proposed sale of 60,000 ACMR shares executed via a stock option exercise and routed through Morgan Stanley Smith Barney on 09/04/2025. The disclosed aggregate market value is $1,586,508.00 and the company has 64,180,965 shares outstanding. The filing also reports a prior sale of 70,000 shares on 09/03/2025 for $1,873,711.00. As a Form 144, this is a compliance notice required for resale by affiliates or persons deemed affiliates and does not by itself convey company performance metrics.

TL;DR: Form 144 appears complete for the proposed sale; includes required acquisition and recent-sale disclosures.

The notice includes the nature of acquisition (stock option exercise), payment method (cash), broker details, and prior sales within three months, aligning with Rule 144 disclosure obligations. The signer represents absence of undisclosed material adverse information. The document contains no additional operational or financial data and does not indicate regulatory or legal concerns based on the provided text.

ACM Research (ACMR) - Avviso Form 144 relativo a una proposta di vendita di 60.000 azioni ordinarie tramite Morgan Stanley Smith Barney in data 09/04/2025, per un valore complessivo di mercato di $1.586.508,00. Le azioni sono state acquisite e saranno vendute a seguito di un esercizio di opzioni su azioni il 09/04/2025, con pagamento effettuato in contanti. Il deposito indica un flottante di 64.180.965 azioni in circolazione. Viene inoltre riportata una vendita recente da parte di Hui Wang di 70.000 azioni il 09/03/2025 per $1.873.711,00. Il dichiarante attesta di non essere a conoscenza di informazioni materiali avverse non divulgate.

ACM Research (ACMR) - Aviso Form 144 que informa sobre una propuesta de venta de 60.000 acciones ordinarias a través de Morgan Stanley Smith Barney el 09/04/2025, por un valor de mercado agregado de $1,586,508.00. Las acciones se adquirieron y se venderán tras un ejercicio de opciones sobre acciones el 09/04/2025, con pago en efectivo. La presentación señala que hay 64,180,965 acciones en circulación. También revela una venta reciente de Hui Wang de 70,000 acciones el 09/03/2025 por $1,873,711.00. El declarante certifica que no tiene conocimiento de información adversa material no divulgada.

ACM Research (ACMR) - Form 144 공고에 따르면 Morgan Stanley Smith Barney를 통해 2025-09-0460,000 보통주를 매도할 예정이며 총 시가 가치는 $1,586,508.00입니다. 해당 주식은 2025-09-04주식옵션 행사로 취득되어 현금으로 결제된 후 매도될 예정입니다. 제출서류에는 총 발행주식수가 64,180,965주로 기재되어 있습니다. 또한 Hui Wang이 2025-09-0370,000주를 $1,873,711.00에 매각한 최근 거래도 공개되어 있습니다. 제출인은 공개되지 않은 중대한 불리한 정보가 없음을 확인합니다.

ACM Research (ACMR) - L'avis Form 144 rapporte une proposition de vente de 60 000 actions ordinaires via Morgan Stanley Smith Barney le 09/04/2025, pour une valeur de marché agrégée de $1,586,508.00. Les actions ont été acquises et seront vendues à la suite d'un exercice d'options sur actions le 09/04/2025, le paiement ayant été effectué en espèces. Le dépôt indique 64,180,965 actions en circulation. Il révèle également une vente récente par Hui Wang de 70,000 actions le 09/03/2025 pour $1,873,711.00. Le déclarant certifie qu'il n'a connaissance d'aucune information défavorable matérielle non divulguée.

ACM Research (ACMR) - Form 144-Meldung berichtet über einen geplanten Verkauf von 60.000 Stammaktien über Morgan Stanley Smith Barney am 09/04/2025 mit einem Gesamtmarktwert von $1.586.508,00. Die Aktien wurden im Zuge der Ausübung einer Aktienoption am 09/04/2025 erworben und werden nach Barausgleich verkauft. Die Einreichung gibt 64.180.965 ausstehende Aktien an. Zudem wird ein kürzlicher Verkauf durch Hui Wang von 70.000 Aktien am 09/03/2025 für $1.873.711,00 offengelegt. Der Einreicher bestätigt, dass ihm keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ACMR Form 144 filed on 09/04/2025 disclose?

The notice discloses a proposed sale of 60,000 ACMR common shares through Morgan Stanley Smith Barney on 09/04/2025 with an aggregate market value of $1,586,508.00.

How were the 60,000 ACMR shares acquired according to the filing?

The shares were acquired via a stock option exercise on 09/04/2025 and payment was made in cash.

Does the filing report any prior sales by the same person?

Yes. It reports that Hui Wang sold 70,000 ACMR shares on 09/03/2025 for $1,873,711.00.

How many ACMR shares are outstanding per the Form 144?

The filing lists 64,180,965 shares outstanding.

Does the filer state they possess undisclosed material information?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.
Acm Research

NASDAQ:ACMR

ACMR Rankings

ACMR Latest News

ACMR Latest SEC Filings

ACMR Stock Data

1.73B
49.89M
15.04%
70.48%
4.9%
Semiconductor Equipment & Materials
Special Industry Machinery, Nec
Link
United States
FREMONT